Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/50709
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Testosterone supplementation for hypogonadal men by the nasal route
Author: Mattern, C.
Hoffman, C.
Morley, J.
Badiu, C.
Citation: The Aging Male, 2008; 11(4):174-178
Publisher: Informa Healthcare
Issue Date: 2008
ISSN: 1368-5538
1473-0790
Statement of
Responsibility: 
Claudia Mattern, Claudia Hoffmann, John E. Morley and Corin Badiu
Abstract: Although multiple forms of testosterone replacement therapy are available to treat hypogonadism, none is ideal. This article reports on the pharmacokinetics of an innovative nasal formulation of testosterone in hypogonadal men. The first study was undertaken in eight men with a baseline total testosterone (TT) of 130.8 ± 87.4 ng/dL and examined the pharmacokinetics of nasal testosterone given in a single dose of 7.6 mg, 15.2 mg or 22.8 mg, respectively. The second study examined the pharmacokinetics of nasal testosterone (7.6 mg) given either twice or three times a day in 21 severely hypogonadal men (baseline TT in 20 patients <50 ng/dL, in one patient 152 ng/dL) for 14 days. The steady-state concentration of testosterone was within the normal range in all treatment groups, but only in the 3-times-a-day group was the 95% confidence interval completely within the physiological range. The average DHT level did not exceed the upper range of normal. The clinical global visual analogue scale improved in the whole group receiving testosterone (p < 0.001). All adverse events in both studies were of mild to moderate intensity and were evaluated as unlikely or not related to the administered study drug. No patients dropped out during treatment. Comparison with the normal circadian rhythm by computer modelling suggests that nasal testosterone can be used to mimic the normal diurnal pattern in eugonadal men. Thus, nasal testosterone can be administered safely to humans in doses that approximate serum concentrations in the normal physiological range.
Keywords: MPP 10; testosterone; DHT; nasal; hypogonadism; circadian rhythm
Description: © 2009 Informa plc
RMID: 0020085851
DOI: 10.1080/13685530802351974
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.